Cardio Catch-Up: Abbott Plans To Expand Pacemaker Market With Leadless Aveir DR

The FDA approved Abbott’s Aveir DR dual-chamber leadless pacemaker system, which will complement Abbott’s Aveir VR technology and help Abbott compete directly with Medtronic in the growing leadless cardiac rhythm management device market.